Novo Nordisk A/S B Shares ADRhedged (NVOH)

Novo Nordisk A/S B Shares ADRhedged (NVOH) is an exchange-traded fund from Precidian Investments' ADRhedged series. It holds American depositary receipts of Novo Nordisk and pairs them with a currency hedge designed to offset fluctuations between the Danish krone and the U.S. dollar.

The goal is to give U.S. investors returns that more closely reflect the local-currency performance of Novo Nordisk's B shares, reducing the effect of exchange-rate moves on the position. Novo Nordisk is a Danish pharmaceutical company based in Bagsvaerd, known for diabetes and obesity treatments, including insulin products and GLP-1 based medicines.